Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
Launched by SOHAG UNIVERSITY · Jan 4, 2024
Trial Information
Current as of July 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different medical imaging methods—PET/CT and MRI—to see which one is better at detecting distant cancer spread, known as metastasis. The goal is to find out which method gives clearer and more accurate results for patients who have been diagnosed with various cancers that have spread from their original location.
To be eligible for this study, participants need to have a confirmed cancer diagnosis and evidence that their cancer has spread. However, certain patients cannot participate, such as those who are pregnant, have specific allergies, or have conditions that make MRI scans unsafe, like certain medical devices in their bodies. The trial is not currently recruiting participants, but when it does, those who join can expect to undergo imaging tests to help doctors understand how effective each method is in finding cancer that has spread. This information could help improve cancer detection in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Only patients with malignancies proven by histology and patients with metastatic lesions proven by histopathology or cytology were included.
- Exclusion Criteria:
- • • As regard the PET/CT study, patients who have the general CT contraindications such as pregnancy, breast feeding, history of allergic reaction to the contrast medium, renal disease, etc.
- • As regard the MRI study, general contraindications including claustrophobia, MR-incompatible pacemakers and MR-incompatible heart valves.
- • Patients whose MRI sequences were incomplete, low-quality and/or had no histopathological evidence of metastatic lesions were eliminated from the study.
- • Low-quality or incomplete MRI included MRI exams with incomplete sequence(s), which is particularly common in elderly patients who are unable to tolerate the scan, or uncooperative patients who do not obey breathing instructions and motion artifacts that may impair images and lead to lower accuracy.
- • Declined consent.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported